Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway.
Medizinisch Genetisches Zentrum, Munich, Germany.
Eur J Hum Genet. 2022 Feb;30(2):150-159. doi: 10.1038/s41431-021-00903-z. Epub 2021 May 13.
The American College of Medical Genetics and Genomics and the Association for Molecular Pathology (ACMG-AMP) system for variant classification is score based with five classes: benign, likely benign, variant of unknown significance (VUS), likely pathogenic, and pathogenic. Here, we present a variant classification model that can be an add-on or alternative to ACMG classification: A stepwise system that can classify any type of genetic variant (e.g., hypomorphic alleles, imprinted alleles, copy number variants, runs of homozygosity, enhancer variants, and variants related to traits). We call it the ABC system because classification is first functional (A), then clinical (B), and optionally a standard comment that fits the clinical question is selected (C). Both steps A and B have 1-5 grading when knowledge is sufficient, if not, class "zero" is assigned. Functional grading (A) only concerns biological consequences with the stages normal function (1), likely normal function (2), hypothetical functional effect (3), likely functional effect (4), and proven functional effect (5). Clinical grading (B) is genotype-phenotype focused with the stages "right type of gene" (1), risk factor (2), and pathogenic (3-5, depending on penetrance). Both grades are listed for each variant and combined to generate a joint class ranging from A to F. Importantly, the A-F classes are linked to standard comments, reflecting laboratory or national policy. In step A, the VUS class is split into class 0 (true unknown) and class 3 (hypothetical functional effect based on molecular predictions or de novo occurrence), providing a rationale for variant-of-interest reporting when the clinical picture could fit the finding. The system gives clinicians a better guide to variant significance.
美国医学遗传学与基因组学学院和分子病理学协会(ACMG-AMP)的变异分类系统是基于评分的,分为五类:良性、可能良性、意义不明的变异(VUS)、可能致病性和致病性。在这里,我们提出了一种可以作为 ACMG 分类的补充或替代方法的变异分类模型:一种逐步系统,可以对任何类型的遗传变异进行分类(例如,功能减弱等位基因、印迹等位基因、拷贝数变异、纯合性延伸、增强子变异以及与特征相关的变异)。我们称之为 ABC 系统,因为分类首先是功能(A),然后是临床(B),并且可以选择适合临床问题的标准注释(C)。如果知识充足,步骤 A 和 B 的分级为 1-5,如果没有,则分配等级“零”。功能分级(A)仅涉及具有正常功能阶段(1)、可能正常功能阶段(2)、假设功能影响阶段(3)、可能功能影响阶段(4)和已证实功能影响阶段(5)的生物学后果。临床分级(B)是基于基因型-表型的,包括“正确的基因类型”(1)、风险因素(2)和致病性(3-5,取决于外显率)。每个变体都列出了这两个等级,并将其组合生成一个从 A 到 F 的联合等级。重要的是,A-F 等级与标准注释相关联,反映了实验室或国家政策。在步骤 A 中,VUS 等级分为 0 级(真正未知)和 3 级(基于分子预测或新生发生的假设功能影响),为在临床情况可能符合发现时报告感兴趣的变异提供了依据。该系统为临床医生提供了更好的变异意义指南。